Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com Related Posts Tech Weekly: NVIDIA Earnings Impress, Bezos Launches AI Startup November 22, 2025 Crypto Market Update: Bitcoin Price Logs Weakest Month Since 2022 November 22, 2025 MP Materials, US Department of Defense Strike Saudi Rare Earths Refinery Deal November 22, 2025